Production (Stage)
Rapid Dose Therapeutics Corp.
RDTCF
$0.1393
-$0.0407-22.61%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.13% | -60.18% | -67.98% | -47.17% | -10.74% |
| Total Depreciation and Amortization | -62.13% | -50.17% | -32.17% | -16.09% | -3.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 169.82% | 589.58% | 357.04% | 181.69% | 9.74% |
| Change in Net Operating Assets | 171.74% | -75.91% | -94.52% | -91.83% | -67.97% |
| Cash from Operations | 50.39% | -126.85% | -439.07% | -268.01% | -158.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -98.77% | -94.35% | -37.16% | 136.52% | 171.25% |
| Total Debt Repaid | 72.55% | 73.26% | 50.06% | -348.36% | -366.63% |
| Issuance of Common Stock | 5.22% | 9,695.96% | 7,949.63% | 30,080.95% | 770.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -61.12% | -61.12% | -- | -- |
| Cash from Financing | -58.66% | 90.01% | 278.19% | 265.32% | 175.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -201.19% | -187.48% | -168.78% | 193.81% | 1,778.33% |